Literature DB >> 15729852

Measuring CAMD technique performance: a virtual screening case study in the design of validation experiments.

Andrew C Good1, Mark A Hermsmeier, S A Hindle.   

Abstract

The dynamic nature and comparatively young age of computational chemistry is such that novel algorithms continue to be developed at a rapid pace. Such efforts are often wrought at the expense of extensive experimental validations of said techniques, preventing a deeper understanding of their potential utility and limitations. Here we address this issue for ligand-based virtual screening descriptors through design of validation experiments that better reflect the aims of real world application. Applying the newly defined chemotype enrichment approach, a variety of two- and three-dimensional (2D/3D) similarity descriptors have been compared extensively across data sets from four diverse target types. The inhibitors within said data sets contain molecules exhibiting a wide array of substructure functionality, size and flexibility, permitting descriptor comparison in myriad settings. Relative descriptor performance under these conditions is examined, including results obtained using more typical virtual screening validation experiments. Guidelines for optimal application of said descriptors are also discussed in the context of the results obtained, as is the potential utility of fingerprint filtering.

Mesh:

Year:  2004        PMID: 15729852     DOI: 10.1007/s10822-004-4067-1

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  13 in total

1.  New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.

Authors:  J S Mason; I Morize; P R Menard; D L Cheney; C Hulme; R F Labaudiniere
Journal:  J Med Chem       Date:  1999-08-26       Impact factor: 7.446

2.  Enhancing the hit-to-lead properties of lead optimization libraries

Authors: 
Journal:  J Chem Inf Comput Sci       Date:  2000-03

3.  A novel shape-feature based approach to virtual library screening.

Authors:  Santosh Putta; Christian Lemmen; Paul Beroza; Jonathan Greene
Journal:  J Chem Inf Comput Sci       Date:  2002 Sep-Oct

4.  Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection.

Authors:  Alexander Golbraikh; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

Review 5.  Factor Xa inhibitors: today and beyond.

Authors:  Jeanine M Walenga; Walter P Jeske; Debra Hoppensteadt; Jawed Fareed
Journal:  Curr Opin Investig Drugs       Date:  2003-03

Review 6.  Why do we need so many chemical similarity search methods?

Authors:  Robert P Sheridan; Simon K Kearsley
Journal:  Drug Discov Today       Date:  2002-09-01       Impact factor: 7.851

7.  Descriptors you can count on? Normalized and filtered pharmacophore descriptors for virtual screening.

Authors:  Andrew C Good; Sung-Jin Cho; Jonathan S Mason
Journal:  J Comput Aided Mol Des       Date:  2004 Jul-Sep       Impact factor: 3.686

8.  Feature trees: a new molecular similarity measure based on tree matching.

Authors:  M Rarey; J S Dixon
Journal:  J Comput Aided Mol Des       Date:  1998-09       Impact factor: 3.686

Review 9.  Perspectives for cancer therapies with cdk2 inhibitors.

Authors:  S Wadler
Journal:  Drug Resist Updat       Date:  2001-12       Impact factor: 18.500

10.  New molecular shape descriptors: application in database screening.

Authors:  A C Good; T J Ewing; D A Gschwend; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  1995-02       Impact factor: 3.686

View more
  13 in total

1.  Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance.

Authors:  Chris Williams
Journal:  Mol Divers       Date:  2006-09-21       Impact factor: 2.943

2.  Managing bias in ROC curves.

Authors:  Robert D Clark; Daniel J Webster-Clark
Journal:  J Comput Aided Mol Des       Date:  2008-02-07       Impact factor: 3.686

3.  Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection?

Authors:  Andrew C Good; Tudor I Oprea
Journal:  J Comput Aided Mol Des       Date:  2008-01-09       Impact factor: 3.686

4.  Evaluation of different virtual screening strategies on the basis of compound sets with characteristic core distributions and dissimilarity relationships.

Authors:  Tomoyuki Miyao; Swarit Jasial; Jürgen Bajorath; Kimito Funatsu
Journal:  J Comput Aided Mol Des       Date:  2019-08-21       Impact factor: 3.686

5.  A constructive approach for discovering new drug leads: Using a kernel methodology for the inverse-QSAR problem.

Authors:  William Wl Wong; Forbes J Burkowski
Journal:  J Cheminform       Date:  2009-04-28       Impact factor: 5.514

6.  Estimation of the applicability domain of kernel-based machine learning models for virtual screening.

Authors:  Nikolas Fechner; Andreas Jahn; Georg Hinselmann; Andreas Zell
Journal:  J Cheminform       Date:  2010-03-11       Impact factor: 5.514

7.  Optimal assignment methods for ligand-based virtual screening.

Authors:  Andreas Jahn; Georg Hinselmann; Nikolas Fechner; Andreas Zell
Journal:  J Cheminform       Date:  2009-08-25       Impact factor: 5.514

Review 8.  Getting the most out of PubChem for virtual screening.

Authors:  Sunghwan Kim
Journal:  Expert Opin Drug Discov       Date:  2016-08-05       Impact factor: 6.098

9.  Optimization and visualization of the edge weights in optimal assignment methods for virtual screening.

Authors:  Lars Rosenbaum; Andreas Jahn; Alexander Dörr; Andreas Zell
Journal:  BioData Min       Date:  2013-03-26       Impact factor: 2.522

10.  Effects of multiple conformers per compound upon 3-D similarity search and bioassay data analysis.

Authors:  Sunghwan Kim; Evan E Bolton; Stephen H Bryant
Journal:  J Cheminform       Date:  2012-11-07       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.